The Food and Drug Administration approved an Actos® (pioglitazone hydrochloride) formulation as a potential therapy for certain high blood sugar, diabetes and type 2 diabetes in adults and children. The medicine was approved for pediatric use in the U. S. by the U. Food and Drug Administration on July 8, 2001. The medicine is marketed as a nonsteroidal, anti-inflammatory and diabetes medicine. The FDA has not approved Actos® for pediatric use. However, the drug is approved for use in adults.
Actos® is marketed as a single dose of 15 mg.
Actos® comes in the form of an oral tablet with an orange-flavored formulation. The product’s active ingredient is pioglitazone hydrochloride. The drug is indicated to treat adults with:
Actos® is indicated for the short-term management of acute hyperglycemia and to treat diabetes, chronic pain and/or nerve damage. The drug is also indicated to reduce the risk of diabetic ketoacidosis and to reduce the risk of developing congestive heart failure.
Actos® was approved in the U. by the Food and Drug Administration on November 14, 2004. It is available in both oral and injectable forms. The injectable form is manufactured by Eli Lilly and Company.
Actos® is indicated for the short-term management of chronic pain and to treat acute pain and/or diabetic neuropathy. The drug is indicated to reduce the risk of diabetic neuropathy and diabetic kidney disease.
The FDA has approved Actos® for use in patients with high blood sugar. The medication is indicated for the short-term management of diabetic kidney disease. The drug is indicated for patients with acute pain and to treat diabetic neuropathy.
Actos® is indicated for the short-term management of acute pain, diabetic neuropathy, diabetic kidney disease, diabetic kidney failure, acute heart failure, acute kidney failure and diabetic nephrolithiasis.
Patients with a history of heart failure, heart failure in adults, heart failure in children, and kidney disease may be given Actos® for the purpose of treating the condition. Patients should not take Actos® if they have taken an ACE inhibitor, such as (R& D) or (R& D) to reduce the risk of acute heart failure.The FDA has approved Actos® for use in children who are not eligible for this medicine. Patients who are not eligible for this medicine may request a refill prior to the first dose. If a patient is not eligible for a dose of Actos® the drug is not dispensed to the patient.
Actos® may be given by injection into an artery or vein to treat a variety of conditions.
The active ingredient in Actos® is pioglitazone hydrochloride.
Actos® is indicated for the short-term management of diabetic ketoacidosis. Patients with ketoacidosis may be given Actos® as an intravenous solution (IV) to help reduce the risk of acute kidney failure.
The drug is indicated for the short-term management of diabetic peripheral neuropathy.
Patients with a history of congestive heart failure, heart failure in adults, and kidney disease may be given Actos® to treat the condition.
Patients should not take Actos® if they have taken an ACE inhibitor, such as (R& D) or (R& D) to reduce the risk of acute kidney failure.
Patients should not take Actos® if they have been diagnosed with congestive heart failure.
Patients who are taking an ACE inhibitor, such as (R& D) or (R& D) may need dose adjustment to avoid acute toxicity.
ObjectiveTo evaluate the effects of Doxycycline (doxycycline) in healthy women of reproductive age (20–50 years).
MethodsA descriptive, cross-sectional descriptive survey was performed. We investigated the association between Doxycycline and age-related infertility. The data were prospectively collected from 2,000 women in the infertility department of our clinic, including the age group 20–49 years, with a range of infertility, which were evaluated on the basis of their age and the duration of infertility. The data were prospectively collected from 7,700 women aged 21–59 years, who were not pregnant, who were undergoing reproductive care, or who had a history of infertility. The participants were invited to the infertility department. The participants were selected by an independent researcher. The study was carried out in the infertility department of our clinic and all the women were interviewed and interviewed with a special person, in a group of women who had been referred to the infertility department with the same diagnosis. The women were asked to fill out questionnaires on the menstrual cycle, their menstrual pain, their infertility history, and their response to the questionnaires. The women were asked to answer the questionnaires on the basis of their menstrual cycle. We conducted an open label, telephone survey to assess the prevalence of the infertility question.
ResultsThe prevalence of the infertility question was 3.8%. The proportion of women in the infertility group was significantly higher than the women in the non-infertility group (23.0% vs. 13.2%). The prevalence of infertility was not statistically significant in either the non-infertility group (16.7% vs. 21.1%), the infertility group (22.2% vs. 13.2%), or the infertility group without the use of doxycycline (13.2% vs. 14.2%).
ConclusionDoxycycline was safe to use in the infertility department in both the non-infertility group and the infertility group. The results of this study indicate that Doxycycline is safe to use in the infertility department.
Citation:Shen Q, Liu Y, Li Q, Wang Y, Zhang S, Li J, Zhang H (2014) Doxycycline and the risk of infertility: a cross-sectional descriptive survey of women in the infertility department. PLoS ONE 6(7): e0242988. https://doi.org/10.1371/journal.pone.0242988
Editor:Mikki D. B. Leung, University of Illinois Chicago, United States of America
Received:August 30, 2014;Accepted:September 28, 2014;Published:October 11, 2014
Copyright:© 2014 Shen et al. This is an open-access article distributed under the terms of the, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability:All data are within the manuscript and cannot be shared in any way.
Funding:This study was financially supported by grants from the National Key R& D Program of China (No. 2016BA01004 and No. 2016BA01004-01), the National Natural Science Foundation of China (No. 11671314 and No. 10814059), and the Natural Science Foundation of Guangdong Province (No. YJ203002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests:The authors have declared that no competing interests exist.
Infertility is a common problem in women []. It has been recognized to affect nearly 20% of all women and affects many different age groups, including young women []. The impact of infertility on women’s health is complex, and there is no consensus about its cause. The first-line treatment for infertility is not clear-cut, but certain medical therapies, such as surgical procedures, are commonly used. These treatment options are associated with a variety of adverse effects, including gastrointestinal complications, bone marrow suppression, and an increased risk of cardiovascular complications, such as heart attack [].
The current medications, Doxycycline and amoxicillin, are used to treat various bacterial infections in women.
Actos, also known as pioglitazone, is an oral medicine used to treat Type 2 diabetes. It works by reducing the amount of glucose produced by the liver, leading to improved glucose control.
The FDA approved Actos in 2011, and in 2012, it was approved to treat type 2 diabetes. However, many people do not realize it’s a diabetes drug. It’s a diabetes drug that is not typically used for any type of medical conditions.
Actos comes in a form of capsules that is taken once a day and is given to patients to decrease their insulin requirements. The medication starts working in as little as 15 minutes. The drug is taken once a day and is not taken every day. The drug is taken by mouth, and is usually taken with food.
Actos has been shown to help people who have diabetes with a reduced risk of serious side effects. It is also used as part of a preventative plan for people who have had a heart attack or have had an irregular heartbeat. This medication may reduce the risk of heart attack, stroke, or kidney disease. It can also help prevent the development of cancer.
In a study comparing Actos with the brand-name Glucophage, researchers found that taking Actos reduced the risk of developing bladder cancer in men with type 2 diabetes. While the results were not statistically significant, they suggested that it may help reduce the risk of bladder cancer in people with type 2 diabetes.
It is a medication that is used to treat type 2 diabetes and is not typically used for any type of medical conditions.
Actos is used to treat type 2 diabetes, and it is used to treat type 1 diabetes. People with type 2 diabetes may need to take Actos for a long time to achieve better results. It can help people with type 2 diabetes to control their blood sugar levels and prevent them from developing serious side effects. Actos is used to treat type 1 diabetes as a preventative medication.
In a study comparing Actos with the brand-name Glucophage, researchers found that taking Actos reduced the risk of developing bladder cancer in people with type 2 diabetes.
It’s a medication that is used to treat type 2 diabetes and is not typically used for any type of medical conditions.
People with type 1 diabetes may need to take Actos for a long time to achieve better results.
Actos is used to treat type 2 diabetes. It is used to treat type 1 diabetes as a preventative medication.
Actos® is used to treat high blood pressure. This medication works by relaxing the blood vessels in your lungs, helping to lower high blood pressure. It comes in a tablet form.
For more information, ask your doctor or pharmacist.
Pharmaceutical companies may produce products that contain certain ingredients that are not included in the product or may be contaminated with undeclared or dangerous substances. Keep all medicine and food you receive, along with any package, and never share your medicine with anyone else.
Actos® is used to treat kidney disease, which may be caused by a genetic condition called hemophilia. This condition may cause fatigue and decreased muscle mass. Some patients may also have reduced kidney function. Kidney disease is a rare condition that can have an impact on your ability to exercise, and should be treated right away. Patients with the condition should consult a doctor for appropriate treatment.
Actos® is used to treat diabetes. This medication may cause diabetes if taken with other diabetes medications (such as metformin) that may cause diabetes. If you are taking Actos® along with blood thinners such as warfarin (Coumadin) or clopidogrel (Plavix), tell your doctor about all the medications you take, including prescription and nonprescription drugs.
If you have diabetes, your doctor may recommend you take Actos®.
Actos® is used to treat liver disease. This medication may cause liver disease if taken with other diabetes medications (such as metformin) that may cause liver disease.
Actos® is used to treat kidney disease. This medication may cause kidney disease if taken with other diabetes medications (such as metformin) that may cause kidney disease.
Actos® is used to treat certain types of cancer. This medication may cause cancer if taken with other cancer drugs (such as rituximab). Call your doctor right away if you develop a fever while taking Actos®. This medication may increase the risk of serious side effects such as kidney damage and heart attack.
If you have been diagnosed with certain types of cancer and have been prescribed Actos®, you should be started on Actos® at the earliest opportunity.
A small number of women taking Actos® will have a breast cancer diagnosis. If you need treatment to prevent a diagnosis of a breast cancer, talk with your doctor about getting the right treatment plan for you.
Women taking Actos® may not have the same types of cancer as the women who have been diagnosed with their breast cancer.
If you are taking Actos® or any other type of medicine called a progestin or hormone medicine, talk with your doctor for further instructions.
A small number of women taking Actos® will have a liver cancer diagnosis. If you need treatment to prevent a diagnosis of a liver cancer, talk with your doctor about getting the right treatment plan for you.
Women taking Actos® may have a lower chance of developing liver cancer than the women who have been diagnosed with their liver cancer. If you need treatment to prevent a diagnosis of a liver cancer, talk with your doctor for further instructions.
If you have been diagnosed with a liver cancer and are taking Actos® or a progestin or hormone medicine, you may need to get a liver cancer screening.
Stade de France Pharmacy